XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Randomized double-blind placebo-controlled trial (RCT) study, to determine the impact of XCHT on irinotecan-induced severe delayed-onset diarrhea (SDOD), and to determine the feasibility of using plasma raloxifene-4\'-glucuronide as a probe for intestinal UGT activity.
Epistemonikos ID: eb95293088a3295ef5cb6005f999c805942a7116
First added on: May 15, 2024